Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors (NCT05824455) | Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd. | 2023-03-23 |
Track Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.